| For: | Pieri A, Harvey J, Bundred N. Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice? World J Clin Oncol 2014; 5(3): 546-553 [PMID: 25114868 DOI: 10.5306/wjco.v5.i3.546] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i3/546.htm |
| Number | Citing Articles |
| 1 |
Meghan R. Flanagan, Mara H. Rendi, Kristine E. Calhoun, Benjamin O. Anderson, Sara H. Javid. Pleomorphic Lobular Carcinoma In Situ: Radiologic–Pathologic Features and Clinical Management. Annals of Surgical Oncology 2015; 22(13) doi: 10.1245/s10434-015-4552-x
|
| 2 |
|
| 3 |
Yume SHOJI, Toru ISHIKAWA, Takashi TASHIRO, Takayo KOBAYASHI, Masayo FUJIMOTO. A Case of Bilateral Pleomorphic Lobular Carcinoma. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2026; 87(3) doi: 10.3919/jjsa.87.302
|
| 4 |
Umar Wazir, Ali Wazir, Clive Wells, Kefah Mokbel. Pleomorphic lobular carcinoma in situ: Current evidence and a systemic review. Oncology Letters 2016; 12(6) doi: 10.3892/ol.2016.5331
|
| 5 |
Matthew Leong, Xiaomo Li, Kai Ying, Helen Nguyen, Eric Vail, Armando Giuliano, Farnaz Dadmanesh. Gene Expression Comparison of Pleomorphic Lobular Carcinoma In-Situ with Classical Lobular Carcinoma In-Situ and High-Grade Ductal Carcinoma In-Situ. Archives of Breast Cancer 2026; 13(2) doi: 10.32768/abc.4597261830-058
|
| 6 |
Daniel I. Hoffman, Paul J. Zhang, Julia Tchou. Breast-conserving surgery for pure non-classic lobular carcinoma in situ: A single institution's experience. Surgical Oncology 2019; 28 doi: 10.1016/j.suronc.2019.01.009
|
| 7 |
Anthony J. Maxwell, Karen Clements, David J. Dodwell, Andrew J. Evans, Adele Francis, Monuwar Hussain, Julie Morris, Sarah E. Pinder, Elinor J. Sawyer, Jeremy Thomas, Alastair Thompson. The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project. The Breast 2016; 27 doi: 10.1016/j.breast.2016.03.004
|
| 8 |
Elizabeth M. Ward, Carol E. DeSantis, Chun Chieh Lin, Joan L. Kramer, Ahmedin Jemal, Betsy Kohler, Otis W. Brawley, Ted Gansler. Cancer statistics: Breast cancer in situ. CA: A Cancer Journal for Clinicians 2015; 65(6) doi: 10.3322/caac.21321
|
| 9 |
Julia L. Savage, Deborah O. Jeffries, Mitra Noroozian, Michael S. Sabel, Julie M. Jorns, Mark A. Helvie. Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes. American Journal of Roentgenology 2018; 211(2) doi: 10.2214/AJR.17.19088
|
| 10 |
Abeer M. Shaaban. Why is LCIS Important—Pathological Review. Current Breast Cancer Reports 2021; 13(3) doi: 10.1007/s12609-021-00415-1
|
| 11 |
Kamaljeet Singh, Cherie Paquette, Elizabeth T. Kalife, Yihong Wang, Shamlal Mangray, M. Ruhul Quddus, Margaret M. Steinhoff. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes. Human Pathology 2018; 78 doi: 10.1016/j.humpath.2018.04.026
|
| 12 |
Batul Al-zubeidy, Nora Hansen. Atypical Breast Proliferative Lesions and Benign Breast Disease. 2018; doi: 10.1007/978-3-319-92657-5_7
|
| 13 |
Amita A. Desai, Rafael E. Jimenez, Tanya L. Hoskin, Courtney N. Day, Judy C. Boughey, Tina J. Hieken. Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast. Annals of Surgical Oncology 2018; 25(10) doi: 10.1245/s10434-018-6591-6
|
| 14 |
Lauren Kopicky, Betty Fan, Stephanie A. Valente. Intraoperative evaluation of surgical margins in breast cancer. Seminars in Diagnostic Pathology 2024; 41(6) doi: 10.1053/j.semdp.2024.06.005
|
| 15 |
Doyoun Woen, Ki Jo Kim, Su Min Lee, Seungah Lee, Kawon Oh, Cho Eun Lee, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Byung Joo Chae, Se Kyung Lee, Jai Min Ryu, Woong Ki Park, Hyunwoo Lee, Jonghan Yu. Clinical Outcomes of Lobular Carcinoma In Situ: Risk of Invasive Cancer Development. Journal of Breast Cancer 2026; 29(2) doi: 10.4048/jbc.2025.0272
|
| 16 |
Gyula Pekar. Encyclopedia of Pathology. Encyclopedia of Pathology 2018; doi: 10.1007/978-3-319-28845-1_4722-1
|
| 17 |
|
| 18 |
Supriya Bevinakoppamath, Adel Mohammed Saleh Ahmed, Shobha Chikkavaddaraguddi Ramachandra, Prashant Vishwanath, Akila Prashant. Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.618172
|
| 19 |
Hannah R. Ray, Erin L. Doren, Karri Adamson, Amanda L. Kong, Chandler S. Cortina. Risk Factors for Skin Flap and Nipple-Areolar Necrosis in Patients Undergoing Nipple-Sparing Mastectomy With Deep Inferior Epigastric Perforator Flap Reconstruction. The American Surgeon™ 2024; 90(11) doi: 10.1177/00031348241250039
|
| 20 |
M. Ferrucci, D. Passeri, F. Milardi, A. Marchet, P. Del Bianco, R. Cappellesso, A.P. Dei Tos. Clinical management and oncologic outcomes of pure pleomorphic and florid lobular carcinoma in situ of the breast: Results from a large single institution experience. European Journal of Surgical Oncology 2025; 51(8) doi: 10.1016/j.ejso.2025.110021
|
| 21 |
Carolina E. Fasola, Jie Jane Chen, Kristin C. Jensen, Kimberly H. Allison, Kathleen C. Horst. Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast. The Breast Journal 2018; 24(1) doi: 10.1111/tbj.12843
|
| 22 |
Yazan A. Masannat, Ehab Husain, Rebecca Roylance, Steven D. Heys, Pauline J Carder, Hiam Ali, Yasmine Maurice, Sarah E. Pinder, Elinor Sawyer, Abeer M. Shaaban. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. The Breast 2018; 38 doi: 10.1016/j.breast.2017.12.011
|
| 23 |
Lauren Q. Chang Sen, Wendie A. Berg, Regina J. Hooley, Gloria J. Carter, Mohamed M. Desouki, Jules H. Sumkin. Core Breast Biopsies Showing Lobular Carcinoma In Situ Should Be Excised and Surveillance Is Reasonable for Atypical Lobular Hyperplasia. American Journal of Roentgenology 2016; 207(5) doi: 10.2214/AJR.15.15425
|
| 24 |
Helena Hwang, Sunati Sahoo. A Comprehensive Guide to Core Needle Biopsies of the Breast. 2016; doi: 10.1007/978-3-319-26291-8_14
|
| 25 |
Paula S. Ginter, Timothy M. D'Alfonso. Current Concepts in Diagnosis, Molecular Features, and Management of Lobular Carcinoma In Situ of the Breast With a Discussion of Morphologic Variants. Archives of Pathology & Laboratory Medicine 2017; 141(12) doi: 10.5858/arpa.2016-0421-RA
|
| 26 |
Megan L. Troxell, Yun An Chen, Jing Yu, Debra M. Ikeda, Kimberly H. Allison. Practical Breast Pathology. 2019; doi: 10.1007/978-3-030-16518-5_4
|
| 27 |
Maria P. Foschini, Rossella Miglio, Roberta Fiore, Chiara Baldovini, Isabella Castellano, Grace Callagy, Simonetta Bianchi, Handan Kaya, Isabel Amendoeira, Patrizia Querzoli, Francesca Poli, Cristian Scatena, Alicia Cordoba, Francesca Pietribiasi, Anikó Kovács, Hana Faistova, Gábor Cserni, Cecily Quinn. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature. European Journal of Surgical Oncology 2019; 45(12) doi: 10.1016/j.ejso.2019.07.011
|
| 28 |
Rachel F. Brem, Anita K. Mehta, Grace M. Thomas. High-Risk Lesions at Minimally Invasive Breast Biopsy: Now What?. Current Radiology Reports 2017; 5(9) doi: 10.1007/s40134-017-0238-4
|
| 29 |
Sarah E. Pinder, Abeer M. Shaaban. Breast Cancer Management for Surgeons. 2018; doi: 10.1007/978-3-319-56673-3_10
|
| 30 |
Sarah E. Pinder, Abeer M. Shaaban. In situ lobular proliferations of the breast. Diagnostic Histopathology 2018; 24(2) doi: 10.1016/j.mpdhp.2017.12.004
|
| 31 |
Stephanie M. Wong, Tari King, Jean-Francois Boileau, William T. Barry, Mehra Golshan. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ. Annals of Surgical Oncology 2017; 24(9) doi: 10.1245/s10434-017-5867-6
|
| 32 |
Mary Ann Sanders, Stephanie M. Wong, Julian Bryan Iorgulescu, Susan C. Lester. Changes and Clarifications in the Eighth Edition of the AJCC Cancer Staging System for Breast Cancer. AJSP: Reviews and Reports 2018; 23(3) doi: 10.1097/PCR.0000000000000239
|